2026 Elizabeth A. Musgrove: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	83	15378	14463	1411	1347	207	38641

Elizabeth A. Musgrove publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Elizabeth A. Musgrove sits on this spectrum.

101 publications 1,796+

This scientist: 207 publications — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Elizabeth A. Musgrove D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Elizabeth A. Musgrove sits on this spectrum.

70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Elizabeth A. Musgrove is affiliated with the University of Glasgow in the United Kingdom. Their research primarily intersects the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on Oncology and Molecular Biology subfields. Specific areas of investigation include Cancer Research and Epidemiology, as well as Periodontics.

The main topics covered by their work include:

Pancreatic and Hepatic Oncology Research
Epigenetics and DNA Methylation
Cancer Genomics and Diagnostics
Neuroendocrine Tumor Research Advances
Dental Health and Care Utilization
Geriatric Care and Nursing Homes
Nosocomial Infections in ICU

Elizabeth A. Musgrove has authored several recent papers, highlighting their engagement with pancreatic cancer and clinical care settings:

Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer, 2020, Gastroenterology
HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer, 2020, Cell Reports
Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence, 2021, Gastroenterology
Current oral care practices in an acute aged care setting: An Australian metropolitan hospital perspective, 2024, International Journal of Speech-Language Pathology

The publication venues where Elizabeth has frequently contributed include:

Gastroenterology
Cell Reports
International Journal of Speech-Language Pathology

Collaboration is notable in their work, with frequent co-authors comprising:

David K. Chang
Andrew V. Biankin
Nigel B. Jamieson
Rosanna Upstill-Goddard
Colin J. McKay

Best Publications

Genomic analyses identify molecular subtypes of pancreatic cancer

Bailey P;Chang Dk;Nones K;Nones K;Johns Al

3672
Citations
Pan-cancer analysis of whole genomes

Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

3090
Citations
Whole genomes redefine the mutational landscape of pancreatic cancer.

Nicola Waddell;Marina Pajic;Ann Marie Patch;David K. Chang

2824
Citations
Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

D W Hedley;M L Friedlander;I W Taylor;C A Rugg

2738
Citations
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Andrew V. Biankin;Andrew V. Biankin;Andrew V. Biankin;Nicola Waddell;Karin S. Kassahn;Marie Claude Gingras

2343
Citations
Biological determinants of endocrine resistance in breast cancer

Elizabeth A. Musgrove;Robert L. Sutherland;Robert L. Sutherland

1680
Citations
Cyclin D as a therapeutic target in cancer

Elizabeth A. Musgrove;C. Elizabeth Caldon;Jane Barraclough;Andrew Stone

1489
Citations
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.

Vinod P. Balachandran;Marta Łuksza;Julia N. Zhao;Vladimir Makarov

1213
Citations
Expression and amplification of cyclin genes in human breast cancer.

M. F. Buckley;K. J. E. Sweeney;J. A. Hamilton;R. L. Sini

971
Citations
Patterns of somatic structural variation in human cancer genomes

Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

942
Citations
Whole-genome landscape of pancreatic neuroendocrine tumours

Aldo Scarpa;David K. Chang;Katia Nones;Katia Nones;Vincenzo Corbo

875
Citations
Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

Owen W. J. Prall;Boris Sarcevic;Elizabeth A. Musgrove;Colin K. W. Watts

622
Citations
Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle

Elizabeth A. Musgrove;Christine S. L. Lee;Michael F. Buckley;Robert L. Sutherland

516
Citations
Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.

S F Doisneau-Sixou;C M Sergio;J S Carroll;R Hui

440
Citations
Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.

E. A. Musgrove;J. A. Hamilton;C. S. L. Lee;K. J. E. Sweeney

428
Citations
PI3K pathway activation in breast cancer is associated with the basal‐like phenotype and cancer‐specific mortality

Elena Lopez-Knowles;Sandra A O'Toole;Catriona M McNeil;Catriona M McNeil;Ewan K. A Millar

405
Citations
Cyclins and breast cancer.

Robert L. Sutherland;Elizabeth A. Musgrove

366
Citations
Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

Christopher J. Ormandy;Elizabeth A. Musgrove;Rina Hui;Roger J. Daly

355
Citations
c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry.

Owen W. J. Prall;Eileen M. Rogan;Elizabeth A. Musgrove;Colin K. W. Watts

353
Citations
The prognostic and predictive value of serum CA19.9 in pancreatic cancer

Jeremy L Humphris;David K Chang;David K Chang;Amber L Johns;Christopher J Scarlett;Christopher J Scarlett

335
Citations

Frequent Co-Authors

Robert L. Sutherland Garvan Institute of Medical Research

Andrew V. Biankin University of Glasgow

James G. Kench Royal Prince Alfred Hospital

Anthony J. Gill University of Sydney

Christopher J. Scarlett University of Newcastle Australia

Marina Pajic Garvan Institute of Medical Research

Roger J. Daly Monash University

Alexander Swarbrick Garvan Institute of Medical Research

Mark J. Cowley Garvan Institute of Medical Research

Sean M. Grimmond University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in the medical field but looking for alternative or supportive career paths, there are several accessible options available online. Pursuing a nursing degree remains popular, and students can start their journey by applying to the easiest bsn program to get into, which can offer a streamlined admissions process.

Another flexible career option is in medical administration and records. Many professionals find success through medical billing and coding schools online with financial aid, which provide important skills for managing patient data and navigating healthcare systems.

For students concerned about entrance exams, exploring nursing schools that don't require teas test can simplify the admissions process and help them get started sooner.

Finally, those interested in leadership roles within healthcare may want to consider earning a healthcare administration degree online. This pathway is ideal for individuals looking to move into management or administrative positions within medical settings.